Failure of Arg-Gly-Asp (RGD)-based inhibitors to reverse integrin-ligand binding has been reported, but the prevalence of this phenomenon among integrin heterodimers is currently unknown. In the present study we have investigated the interaction of four different RGD-binding integrins (α5β1, αVβ1, αVβ3 and αVβ6) with fibronectin (FN) using surface plasmon resonance. The ability of inhibitors to reverse ligand binding was assessed by their capacity to increase the dissociation rate of pre-formed integrin–FN complexes. For all four receptors we showed that RGD-based inhibitors (such as cilengitide) were completely unable to increase the dissociation rate. Formation of the non-reversible state occurred very rapidly and did not rely on the time-dependent formation of a high-affinity state of the integrin, or the integrin leg regions. In contrast with RGD-based inhibitors, Ca2+ (but not Mg2+) was able to greatly increase the dissociation rate of integrin–FN complexes, with a half-maximal response at ~0.4 mM Ca2+ for αVβ3–FN. The effect of Ca2+ was overcome by co-addition of Mn2+, but not Mg2+. A stimulatory anti-β1 monoclonal antibody (mAb) abrogated the effect of Ca2+ on α5β1–FN complexes; conversely, a function-blocking mAb mimicked the effect of Ca2+. These results imply that Ca2+ acts allosterically, probably through binding to the adjacent metal-ion-dependent adhesion site (ADMIDAS), and that the α1 helix in the β subunit I domain is the key element affected by allosteric modulators. The data suggest an explanation for the limited clinical efficacy of RGD-based integrin antagonists, and we propose that allosteric antagonists could prove to be of greater therapeutic benefit.
Skip Nav Destination
Article navigation
December 2014
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Rapid Communication|
December 05 2014
Disruption of integrin–fibronectin complexes by allosteric but not ligand-mimetic inhibitors
A. Paul Mould;
A. Paul Mould
1
*Biomolecular Analysis Core Facility, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester M13 9PT, U.K.
1To whom correspondence should be addressed (email paul.mould@manchester.ac.uk).
Search for other works by this author on:
Susan E. Craig;
Susan E. Craig
†Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, U.K.
Search for other works by this author on:
Sarah K. Byron;
Sarah K. Byron
†Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, U.K.
Search for other works by this author on:
Martin J. Humphries;
Martin J. Humphries
†Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, U.K.
Search for other works by this author on:
Thomas A. Jowitt
Thomas A. Jowitt
*Biomolecular Analysis Core Facility, Faculty of Life Sciences, Michael Smith Building, University of Manchester, Manchester M13 9PT, U.K.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
August 13 2014
Revision Received:
October 17 2014
Accepted:
October 21 2014
Accepted Manuscript online:
October 21 2014
Online ISSN: 1470-8728
Print ISSN: 0264-6021
© The Authors Journal compilation © 2014 Biochemical Society
2014
Biochem J (2014) 464 (3): 301–313.
Article history
Received:
August 13 2014
Revision Received:
October 17 2014
Accepted:
October 21 2014
Accepted Manuscript online:
October 21 2014
Citation
A. Paul Mould, Susan E. Craig, Sarah K. Byron, Martin J. Humphries, Thomas A. Jowitt; Disruption of integrin–fibronectin complexes by allosteric but not ligand-mimetic inhibitors. Biochem J 15 December 2014; 464 (3): 301–313. doi: https://doi.org/10.1042/BJ20141047
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.